Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study.
Miyaoka T, Wake R, Furuya M, Liaury K, Ieda M, Kawakami K, Tsuchie K, Taki M, Ishihara K, Araki T, Horiguchi J. Miyaoka T, et al. Among authors: horiguchi j. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jun 1;37(2):222-6. doi: 10.1016/j.pnpbp.2012.02.002. Epub 2012 Feb 10. Prog Neuropsychopharmacol Biol Psychiatry. 2012. PMID: 22349578 Clinical Trial.
Minocycline improves recognition memory and attenuates microglial activation in Gunn rat: a possible hyperbilirubinemia-induced animal model of schizophrenia.
Liaury K, Miyaoka T, Tsumori T, Furuya M, Hashioka S, Wake R, Tsuchie K, Fukushima M, Limoa E, Tanra AJ, Horiguchi J. Liaury K, et al. Among authors: horiguchi j. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3;50:184-90. doi: 10.1016/j.pnpbp.2013.12.017. Epub 2014 Jan 2. Prog Neuropsychopharmacol Biol Psychiatry. 2014. PMID: 24389395
Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial.
Miyaoka T, Kanayama M, Wake R, Hashioka S, Hayashida M, Nagahama M, Okazaki S, Yamashita S, Miura S, Miki H, Matsuda H, Koike M, Izuhara M, Araki T, Tsuchie K, Azis IA, Arauchi R, Abdullah RA, Oh-Nishi A, Horiguchi J. Miyaoka T, et al. Among authors: horiguchi j. Clin Neuropharmacol. 2018 Sep/Oct;41(5):151-155. doi: 10.1097/WNF.0000000000000299. Clin Neuropharmacol. 2018. PMID: 30234616 Clinical Trial.
Possible antipsychotic effects of minocycline in patients with schizophrenia.
Miyaoka T, Yasukawa R, Yasuda H, Hayashida M, Inagaki T, Horiguchi J. Miyaoka T, et al. Among authors: horiguchi j. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):304-7. doi: 10.1016/j.pnpbp.2006.08.013. Epub 2006 Oct 5. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17030375
Yi-gan san for the treatment of borderline personality disorder: an open-label study.
Miyaoka T, Furuya M, Yasuda H, Hayashia M, Inagaki T, Horiguchi J. Miyaoka T, et al. Among authors: horiguchi j. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):150-4. doi: 10.1016/j.pnpbp.2007.07.026. Epub 2007 Aug 8. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 17765378 Clinical Trial.
427 results